Advanced Oncotherapy PLC Share Price London S.E.
Equities
GB00B16JQ761
Advanced Medical Equipment & Technology
End-of-day quote
Other stock markets
|
||
- GBX | - |
05-09 | Advanced Oncotherapy Delists from London Bourse Amid Financing Deal | MT |
05-03 | Advanced Oncotherapy financing talks continue, funds delayed | AN |
Sales 2020 | - | Sales 2021 | - | Capitalization | 172M 13.54B |
---|---|---|---|---|---|
Net income 2020 | -25M -1.97B | Net income 2021 | -29M -2.29B | EV / Sales 2020 | - |
Net Debt 2020 | 48.32M 3.81B | Net Debt 2021 | 49.09M 3.87B | EV / Sales 2021 | - |
P/E ratio 2020 |
-4.11
x | P/E ratio 2021 |
-4.93
x | Employees | - |
Yield 2020 * |
-
| Yield 2021 |
-
| Free-Float | 52.47% |
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 49 | 26/08/14 | |
Director of Finance/CFO | - | 30/09/16 | |
Michael Sinclair
CHM | Chairman | 82 | 15/06/06 |
Members of the board | Title | Age | Since |
---|---|---|---|
Lori Cross
BRD | Director/Board Member | 64 | 28/09/20 |
Michael Sinclair
CHM | Chairman | 82 | 15/06/06 |
Hans von Celsing
BRD | Director/Board Member | 74 | 25/01/17 |
1st Jan change | Capi. | |
---|---|---|
+12.50% | 229B | |
+14.52% | 195B | |
+17.51% | 142B | |
+28.96% | 109B | |
+3.27% | 64.85B | |
+18.16% | 54.33B | |
+7.63% | 52.09B | |
+10.95% | 45.15B | |
+5.10% | 37.39B |